Methyl 2,3-diaminobenzoate

Established in 2015, Speranza Chemical operates a 1,500-square-meter R&D center staffed by PhD-level chemists developing innovative synthetic processes for pharmaceutical intermediates, electronic chemical intermediates, and advanced functional materials, with dozens of products scaled up to commercial production. The company manufactures and exports a very extensive catalog of fine chemicals and chiral intermediates, offers international certification and rich product-line capacity, and ships to customers across North America, Europe, Asia, the Middle East, Africa, and Oceania.